An improved pseudotargeted metabolomics approach using multiple ion monitoring with time-staggered ion lists based on ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry

Analytica Chimica Acta

Volumn 927, Issue , 2016, Pages 82-88

  Wang, Yang ^a   Liu, Fang ^a   Li, Peng ^a   He, Chengwei ^a   Wang, Ruibing ^a   Su, Huanxing ^a   Wan, Jian Bo ^a  

^a UNIVERSITY OF MACAU   (Macao)

Author keywords

Alcohol induced liver injury; Multiple ion monitoring; Pseudotargeted metabolomics; Time staggered ion lists

Indexed keywords

DISEASES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

FLIGHT MASS SPECTROMETRY; ION MONITORING; LIVER INJURIES; METABOLOMIC ANALYSIS; METABOLOMICS; QUADRUPOLE MASS SPECTROMETRY; TIME-STAGGERED ION LISTS; ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHIES;

IONS;

ALCOHOL; BIOLOGICAL MARKER; DRUG METABOLITE; ION;

ALCOHOL LIVER CIRRHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; ION MONITORING; LINEAR SYSTEM; MEASUREMENT REPEATABILITY; METABOLOMICS; MOUSE; MULTIPLE ION MONITORING; NONHUMAN; PRIORITY JOURNAL; PSEUDOTARGETED METABOLOMICS; QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; BLOOD; C57BL MOUSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER CIRRHOSIS; MASS SPECTROMETRY; PROCEDURES; REPRODUCIBILITY;

ANIMALS; BIOMARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIVER CIRRHOSIS; MASS SPECTROMETRY; METABOLOMICS; MICE; MICE, INBRED C57BL; REPRODUCIBILITY OF RESULTS;

EID: 84969135117     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2016.05.008     Document Type: Article

References (28)

1. Wang Y., Liu S., Hu Y., Li P., Wan J.B. Current state of the art of mass spectrometry-based metabolomics studies - a review focusing on wide coverage, high throughput and easy identification. RSC Adv. 2015, 5:78728-78737.
2. Yin P., Xu G. Current state-of-the-art of nontargeted metabolomics based on liquid chromatography-mass spectrometry with special emphasis in clinical applications. J. Chromatogr. 2014, A 1374:1-13.
3. Nicholson J.K., Lindon J.C. Systems biology: metabonomics. Nature 2008, 455:1054-1056.
4. Gika H.G., Theodoridis G.A., Plumb R.S., Wilson I.D. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics. J. Pharm. Biomed. Anal. 2014, 87:12-25.
5. Colombo M., Sirtori F.R., Rizzo V. A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer. Rapid Commun. Mass Spectr. 2004, 18:511-517.
6. Ranasinghe A., Ramanathan R., Jemal M., D'Arienzo C.J., Humphreys W.G., Olah T.V. Integrated quantitative and qualitative workflow for in vivo bioanalytical support in drug discovery using hybrid Q-TOF-MS. Bioanalysis 2012, 4:511-528.
7. Dams R., Huestis M.A., Lambert W.E., Murphy C.M. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. J. Am. Soc. Mass Spectr. 2003, 14:1290-1294.
8. Lange E., Tautenhahn R., Neumann S., Gröpl C. Critical assessment of alignment procedures for LC-MS proteomics and metabolomics measurements. BMC Bioinforma. 2008, 9:375.
9. Peters S., van Velzen E., Janssen H.-G. Parameter selection for peak alignment in chromatographic sample profiling: objective quality indicators and use of control samples. Anal. Bioanal. Chem. 2009, 394:1273-1281.
10. Griffiths W.J., Koal T., Wang Y., Kohl M., Enot D.P., Deigner H.P. Targeted metabolomics for biomarker discovery. Angew. Chem. Int. Ed. 2010, 49:5426-5445.
11. Shushan B. A review of clinical diagnostic applications of liquid chromatography-tandem mass spectrometry. Mass Spectrom. Rev. 2010, 29:930-944.
12. Kitteringham N.R., Jenkins R.E., Lane C.S., Elliott V.L., Park B.K. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J. Chromatogr. 2009, B 877:1229-1239.
13. Chen S., Kong H., Lu X., Li Y., Yin P., Zeng Z., Xu G. Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography/triple quadrupole mass spectrometry. Anal. Chem. 2013, 85:8326-8333.
14. Shao Y., Zhu B., Zheng R., Zhao X., Yin P., Lu X., Jiao B., Xu G., Yao Z. Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery. J. Proteom. Res. 2015, 14:906-916.
15. Yang T., Luo P., Li Y., Hua R., Yin P., Xu G. A serum metabolomics study of gastric cancer based on pseudotargeted liquid chromatography-mass spectrometry approach. Se Pu 2014, 32:126-132.
16. Luo P., Dai W., Yin P., Zeng Z., Kong H., Zhou L., Wang X., Chen S., Lu X., Xu G. MRM-ion pair finder: a systematic approach to transform non-targeted mode to pseudo-targeted mode for metabolomics study based on liquid chromatography-mass spectrometry. Anal. Chem. 2015, 87:5050-5055.
17. Zeng Z., Liu X., Dai W., Yin P., Zhou L., Huang Q., Lin X., Xu G. Ion fusion of high-resolution LC-MS-based metabolomics data to discover more reliable biomarkers. Anal. Chem. 2014, 86:3793-3800.
18. Johnson A.R., Carlson E.E. Collision-induced dissociation mass spectrometry: a powerful tool for natural product structure elucidation. Anal. Chem. 2015, 87:10668-10678.
19. Kuehnbaum N.L., Britz-McKibbin P. New advances in separation science for metabolomics: resolving chemical diversity in a post-genomic era. Chem. Rev. 2013, 113:2437-2468.
20. Calderón-Santiago M.n., Priego-Capote F., Luque de Castro M.A.D. Enhanced detection and identification in metabolomics by use of LC-MS/MS untargeted analysis in combination with gas-phase fractionation. Anal. Chem. 2014, 86:7558-7565.
21. Yan Z., Yan R. Improved data-dependent acquisition for untargeted metabolomics using gas-phase fractionation with staggered mass range. Anal. Chem. 2015, 87:2861-2868.
22. Yao M., Ma L., Humphreys W.G., Zhu M. Rapid screening and characterization of drug metabolites using a multiple ion monitoring-dependent MS/MS acquisition method on a hybrid triple quadrupole-linear ion trap mass spectrometer. J. Mass Spectrom. 2008, 43:1364-1375.
23. Chindarkar N.S., Park H.D., Stone J.A., Fitzgerald R.L. Comparison of different time of flight-mass spectrometry modes for small molecule quantitative analysis. J. Anal. Toxicol. 2015, 39:675-685.
24. Lieber C.S., Robins S.J., Li J., DeCarli L.M., Mak K.M., Fasulo J.M., Leo M.A. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 1994, 106. 152-152.
25. Chirkin A.A., Konevalova N.Y., Grebennikov I.N., Kulikov V.A., Saraev Y.V., Buko V.U., Chirkina I.A., Danchenko E.O., Gundermann K.J. Effect of polyunsaturated phosphatidyl-choline on lipid transport system in alcoholic liver injury. Addict. Biol. 1998, 3:65-70.
26. Li S., Liu H., Jin Y., Lin S., Cai Z., Jiang Y. Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice. J. Chromatogr. 2011, B 879:2369-2375.
27. Liu F., Bai X., Ding R.B., Hu Y.J., Su H., Wan J.B. UPLC/Q-TOFMS-Based metabolomics studies on the protective effect of panax notoginseng saponins on alcoholic liver injury. Am. J. Chin. Med. 2015, 43:695-714.
28. Gu H., Zhang P., Zhu J., Raftery D. Globally optimized targeted mass spectrometry: reliable metabolomics analysis with broad coverage. Anal. Chem. 2015, 87:12355-12362.